These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 26434203)
1. [Position Statement of Hungarian Epilepsy League: The use of valproate preparations for epilepsy in pregnancy and in women of childbearing age]. Janszky J; Ideggyogy Sz; 2015 Mar; 68(3-4):143. PubMed ID: 26434203 [No Abstract] [Full Text] [Related]
2. Valproic acid: long-term effects on children exposed in utero. Prescrire Int; 2009 Dec; 18(104):253-7. PubMed ID: 20025093 [TBL] [Abstract][Full Text] [Related]
3. [Valproic acid during pregnancy lowers IQ in children]. Versicherungsmedizin; 2013 Sep; 65(3):172. PubMed ID: 24137907 [No Abstract] [Full Text] [Related]
4. Valproate in the treatment of epilepsy in girls and women of childbearing potential. Tomson T; Marson A; Boon P; Canevini MP; Covanis A; Gaily E; Kälviäinen R; Trinka E Epilepsia; 2015 Jul; 56(7):1006-19. PubMed ID: 25851171 [TBL] [Abstract][Full Text] [Related]
5. What can we say to women of reproductive age with epilepsy? Penovich P; Gaily E Neurology; 2005 Mar; 64(6):938-9. PubMed ID: 15781803 [No Abstract] [Full Text] [Related]
6. Dangers of valproate in pregnancy. Wieck A; Jones S BMJ; 2018 Apr; 361():k1609. PubMed ID: 29669728 [No Abstract] [Full Text] [Related]
7. Valproate and pregnancy: think again. Kalayjian LA Neurology; 2015 Jan; 84(4):e25-6. PubMed ID: 25628438 [No Abstract] [Full Text] [Related]
8. [Caution and warning: About valproate and pregnancy]. Masson M; Huberfeld G; Richa S; Henry C; Gaillard R Encephale; 2016 Oct; 42(5):391-394. PubMed ID: 27842894 [No Abstract] [Full Text] [Related]
9. Prevalence, utilization, and costs of antiepileptic drugs for epilepsy in Germany--a nationwide population-based study in children and adults. Hamer HM; Dodel R; Strzelczyk A; Balzer-Geldsetzer M; Reese JP; Schöffski O; Graf W; Schwab S; Knake S; Oertel WH; Rosenow F; Kostev K J Neurol; 2012 Nov; 259(11):2376-84. PubMed ID: 22544296 [TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of anti-epileptic drug therapies with specific focus on teratogenic outcomes. Jentink J; Boersma C; de Jong-van den Berg LT; Postma MJ J Med Econ; 2012; 15(5):862-8. PubMed ID: 22494266 [TBL] [Abstract][Full Text] [Related]
11. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F; Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013 [TBL] [Abstract][Full Text] [Related]
12. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? Montouris G; Abou-Khalil B Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728 [TBL] [Abstract][Full Text] [Related]
13. France steps up warning measures for valproate drugs. Casassus B Lancet; 2016 Mar; 387(10024):1148. PubMed ID: 27025323 [No Abstract] [Full Text] [Related]
14. Type of Prenatal Antiseizure Drug Matters for Children's Autism Risk. Harris E JAMA; 2024 May; 331(18):1525. PubMed ID: 38639978 [No Abstract] [Full Text] [Related]
15. Australian pregnancy registry of women taking antiepileptic drugs. Vajda F; Lander C; O'brien T; Hitchcock A; Graham J; Solinas C; Eadie M; Cook M Epilepsia; 2004 Nov; 45(11):1466. PubMed ID: 15509252 [No Abstract] [Full Text] [Related]
16. Weighing the risks of valproate in women who could become pregnant. Angus-Leppan H; Liu RSN BMJ; 2018 Apr; 361():k1596. PubMed ID: 29669717 [No Abstract] [Full Text] [Related]
17. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy. Tomson T; Perucca E; Battino D Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670 [TBL] [Abstract][Full Text] [Related]
18. [Evaluation of antiepileptic therapy during pregnancy]. Laskowska M; Leszczyńska-Gorzelak B; Oleszczuk J Ginekol Pol; 2002 Jan; 73(1):35-42. PubMed ID: 12001761 [TBL] [Abstract][Full Text] [Related]
19. Is there a difference between various presentations of valproate for cognitive outcome after in utero exposure? Gelisse P; Genton P; Crespel A Epilepsia; 2016 Mar; 57(3):523-4. PubMed ID: 26948846 [No Abstract] [Full Text] [Related]